[TNXP] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 3.17%
YoY- -24.94%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 3,779 3,989 0 33,902 0 0 9,027 -43.94%
PBT -27,322 -27,975 -28,356 -33,005 -31,680 -28,981 -23,140 11.67%
Tax -0 -1,216 29,002 -1,790 5,611 0 -196 -
NP -27,322 -27,975 -28,356 -33,005 -34,084 -28,981 -27,395 -0.17%
Tax Rate - - - - - - - -
Total Cost 31,101 31,964 28,356 66,907 34,084 28,981 36,422 -9.96%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -723.00 -701.30 0.00 -100.00 0.00 0.00 -254.17 100.37%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -27.53 -58.40 -85.71 -102.85 -111.06 -4.24 -244.55 -76.59%
EPS Diluted -27.53 -58.40 -85.71 -102.85 -111.06 -4.24 -244.55 -76.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.